The world's sporting eyes will be turned towards London in July 2012 for the Olympic Games. The opening ceremony on 27 July will mark the culmination of an enormous amount of hard work since London was announced as the host city in July 2005. London, lest we forget, was awarded the 30th Summer Games on the back of its commitment to a lasting health and social legacy. It therefore seems opportune to reflect on how the Olympics might have an impact on rheumatology, and perhaps of more relevance, how the rheumatology community can aspire to contribute to the Olympic legacy.
UK rheumatology will contribute to the Games in a variety of ways. Some of our clinical colleagues are working as members of Team GB or the various national governing bodies. Current approaches to managing inflammatory arthritis enable patients to achieve and maintain high functional performance. Some of our patients may well be competing at the Olympic or Paralympic Games, requiring support from their clinical rheumatology teams. I am sure some of our colleagues and patients will have offered their time as one of 70 000 London Organising Committee of the Olympic Games and Paralympic Games volunteers, and there will be many more who are spectators at the 37 competition venues. The majority, however, will follow 14 700 of the world's sporting elite competing for the coveted gold medal through television, radio and the Internet. The 2012 Olympics and Paralympics will see unprecedented live coverage, with the BBC alone presenting 340 h of live feed every day (yes, that is the equivalent of 14 days of live feed across its digital TV and Internet channels every day). Whether you love or hate sport, it is going to be almost impossible to escape the Olympics, and therein lies the most important legacy opportunity, to promote the benefits of physical activity.
Low cardiorespiratory fitness (CRF) is probably the world's most important non-communicable disease public health risk factor. The importance of low CRF cannot be overstated and when considered alongside other all-cause mortality risk factors is of greater importance than the combined risks of smoking, obesity and diabetes [1] . If you can spare 7 min, I recommend you watch a video clip by Dr Mike Evans, founder of the Health Design Lab (http://www.youtube.com/watch?v= aUaInS6HIGo&feature=share).
Rheumatologists are already well aware of the impact that cardiovascular disease has on our patients' well-being [2] , which is reflected in the considerable efforts that we go to in collaboration with general practitioner colleagues to ensure that our patients' lipid profile is optimized, obesity addressed, hypertension appropriately managed and smoking cessation advice and support offered. Such primary and secondary health care prevention is admirable and to be applauded, but perhaps should be seen in the context that addressing these individual risk factors will not yield the public health benefits of improving CRF through the promotion of increased physical activity.
While patients with inflammatory arthritis are known to be less physically active than the general population, relatively little is known about the quality of physical activity advice offered by rheumatology teams. The perception among some patients is that rheumatology health professionals may lack the expertise to confidently prescribe exercise [3] . An audit in our own department has revealed that more than 90% of our patients were aware of the benefits of regular physical activity, 95% perceived regular exercise to be safe but <50% had received information on exercise and physical activity.
That is not to say that rheumatology teams do not promote physical activity as part of general health advice, but I doubt whether the investment and resources given to promoting physical activity and the prescription of exercise is comparable with that given to lowering cholesterol, smoking cessation, bariatric medical and surgical treatments and managing hypertension. Unfortunately the cure for low CRF is not (yet!; http://news.bbc.co.uk/1/hi/ health/7535770.stm) a drug and has not received the kind of investment associated with the pharmaceutical industry's development and promotion of a new product. It is worth considering that during 2010, Pfizer generated more than $11 billion of sales from its lipid-lowering drug Lipitor.
The importance of physical activity is not confined to our patients. The rheumatology community is aware of Dame Carol Black's work in promoting well-being at work [4] , and central to that philosophy is the promotion of physical activity by employers and the provision of opportunities for employees to be physically active. I am sure there is not a rheumatology team in the UK that has not been asked to justify its spending on biologic therapies against the appropriate National Institute for Health and Clinical Excellence (NICE) guidance, yet I wonder how many departments work in trusts that provide well-being programmes and apply and monitor the NICE guidance on promoting physical activity in the workplace [5] . The importance of employee well-being is of great interest to the top multi-nationals who invest heavily in well-being programmes and realize a significant return on that investment through reduced absenteeism, increased presenteeism, improved productivity and enhanced recruitment and retention [6] .
Some of you will be reading this with a degree of complacency as individuals who achieve the recommended 30 min of moderately vigorous physical activity five times a week [7] , so I will close by bringing to your attention the evidence that suggests that prolonged inactivity is a significant contributor to all-cause mortality [8, 9] . In essence, if you are active for 30 min of the day but then spend the remaining 23.5 h being sedentary through sleep, commuting, working at your desk, commuting and then reclining in front of your flat screen computer or TV, you risk significantly undermining the physiological benefits of your 30 min of exercise. Put another way, if I offered you a tablet that had no risk factors and that had proven benefits for reducing heart disease, stroke, cancer, diabetes and Alzheimer's, and then told you that the recommended dose was one tablet five times a week but that you would gain even more benefit by taking extra tablets without risk, what dose would you take?
The London 2012 Olympic and Paralympic Games provide the opportunity to focus a nation's mind on physical activity, so let us use that opportunity to improve the well-being of ourselves and our patients by making a sustainable commitment to increase levels of CRF through physical activity and thereby help achieve a real Olympic legacy.
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